BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 2783924)

  • 1. Comprehensive evaluation of complement components in the course of type I (Lepra) and type II (ENL) reactions.
    Sehgal VN; Sharma V; Sharma VK
    Int J Dermatol; 1989; 28(1):32-5. PubMed ID: 2783924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An appraisal of third complement component (C3) and breakdown product (C3d) in erythema nodosum leprosum (ENL).
    Saha K; Chakraborty AK; Sharma V; Sehgal VN
    Lepr Rev; 1982 Dec; 53(4):253-60. PubMed ID: 6984124
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum immune complexes in erythema nodosum leprosum reactions of leprosy.
    Rao TD; Rao PR
    Indian J Lepr; 1988 Apr; 60(2):189-95. PubMed ID: 3142953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breakdown product of factor B as an index of complement activation in lepromatous leprosy and its relation with bacillary load.
    Saha K; Sharma V; Chakrabarty AK; Sehgal VN
    Scand J Immunol; 1983 Jan; 17(1):37-43. PubMed ID: 6342123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of anti-reactional drugs on complement components in the type II, erythema nodosum leprosum, reaction.
    Sehgal VN; Sharma V; Sharma VK
    Br J Dermatol; 1988 Aug; 119(2):255-8. PubMed ID: 3166944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential immunoglobulin and complement levels in leprosy prior to development of reversal reaction and erythema nodosum leprosum.
    Amorim FM; Nobre ML; Nascimento LS; Miranda AM; Monteiro GRG; Freire-Neto FP; Queiroz MDCP; Queiroz JW; Duthie MS; Costa MR; Reed SG; Johnson WD; Dupnik KM; Jeronimo SMB
    PLoS Negl Trop Dis; 2019 Jan; 13(1):e0007089. PubMed ID: 30689631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levels of some complement components in azoospermic, oligospermic and normospermic Nigerian men.
    Oyeyinka GO; Bello CS; Elegba OY; Nsofor BI
    J Reprod Med; 1987 Oct; 32(10):774-6. PubMed ID: 3500310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Activity of total complement and concentration of its components C1q, C3, C4 and C1-inactivator in cancer].
    Matoses Cuquerella S; O'Connor Miquel C; Lluch Hernández AM; García-Conde Bru J
    Med Clin (Barc); 1988 Dec; 91(20):769-74. PubMed ID: 3266280
    [No Abstract]   [Full Text] [Related]  

  • 9. Complement activation in fetuses: assessment by the levels of complement components and split products in cord blood.
    Miyano A; Nakayama M; Fujita T; Kitajima H; Imai S; Shimizu A
    Diagn Clin Immunol; 1987; 5(2):86-90. PubMed ID: 3497734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement determinations in the synovial fluid and serum of a patient with Erythema nodosum leprosum.
    Louie JS; Glovsky M
    Int J Lepr Other Mycobact Dis; 1975; 43(3):252-5. PubMed ID: 1240873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune complexes and complement hypercatabolism in patients with leprosy.
    Bjorvatn B; Barnetson RS; Kronvall G; Zubler RH; Lambert PH
    Clin Exp Immunol; 1976 Dec; 26(3):388-96. PubMed ID: 1009681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement aberrations in serum from children with otitis due to S. pneumoniae or H. influenzae.
    Prellner K; Nilsson NI
    Acta Otolaryngol; 1982; 94(3-4):275-82. PubMed ID: 6983204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune complexes in leprosy patients from an endemic and a nonendemic area and a longitudinal study of the relationship between complement breakdown products and the clinical activity of erythema nodosum leprosum.
    Valentijn RM; Faber WR; Lai A Fat RF; Chan Pin Jie JC; Daha MR; van Es LA
    Clin Immunol Immunopathol; 1982 Feb; 22(2):194-202. PubMed ID: 6980747
    [No Abstract]   [Full Text] [Related]  

  • 14. Influence of age and sex on serum complement components in children.
    Roach B; Kim Y; Jerome E; Michael AF
    Am J Dis Child; 1981 Oct; 135(10):918-20. PubMed ID: 6975036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement components in Nigerians with bronchial asthma.
    Onyemelukwe GC
    Ann Allergy; 1989 Oct; 63(4):309-12. PubMed ID: 2802267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solubilization of preformed immune complexes in sera of patients with type 1 and type 2 lepra reactions.
    Chakrabarty AK; Kashyap A; Sehgal VN; Saha K
    Int J Lepr Other Mycobact Dis; 1988 Dec; 56(4):559-65. PubMed ID: 3221112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes of serum complement concentrations in tumour patients prior and after radiotherapy.
    Beyer-Enke SA; Strauss LG; Georgi M
    Strahlenther Onkol; 1986 Jul; 162(7):441-7. PubMed ID: 3488595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement components, complement activation, and acute phase response in systemic lupus erythematosus.
    Sturfelt G; Sjöholm AG
    Int Arch Allergy Appl Immunol; 1984; 75(1):75-83. PubMed ID: 6086533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement changes in falciparum malaria infection.
    Phanuphak P; Hanvanich M; Sakulramrung R; Moollaor P; Sitprija V; Phanthumkosol D
    Clin Exp Immunol; 1985 Mar; 59(3):571-6. PubMed ID: 3886219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Humoral immune system in inflammatory bowel disease: I. Complement levels.
    Hodgson HJ; Potter BJ; Jewell DP
    Gut; 1977 Sep; 18(9):749-53. PubMed ID: 604196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.